The US FDA’s proposed rule on laboratory-developed tests: Impacts on clinical laboratory testing

Posted on May 26, 2024 By LabLynx Journal articles

Motretinide
Names
IUPAC name
N-Ethyl-3-methoxy-2-methyl-1,2,3,4-tetradehydro-17-norretinamide
Systematic IUPAC name
(2E,4E,6E,8E)-N-Ethyl-8-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenamide
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.054.613 Edit this at Wikidata
EC Number
  • 260-094-6
KEGG
UNII
  • InChI=1S/C23H31NO2/c1-8-24-23(25)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(26-7)20(6)19(21)5/h9-15H,8H2,1-7H3,(H,24,25)/b11-9+,13-12+,16-10+,17-14+ ☒N
    Key: IYIYMCASGKQOCZ-DJRRULDNSA-N ☒N
  • InChI=1/C23H31NO2/c1-8-24-23(25)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(26-7)20(6)19(21)5/h9-15H,8H2,1-7H3,(H,24,25)/b11-9+,13-12+,16-10+,17-14+
    Key: IYIYMCASGKQOCZ-DJRRULDNBU
  • CCNC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C
Properties
C23H31NO2
Molar mass 353.49774
Pharmacology
D10AD05 (WHO)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Motretinide is an anti-acne preparation and aromatic analog of retinoic acid.[1]

References

  1. ^ Zouboulis, C. C. (2001). "Retinoids--which dermatological indications will benefit in the near future?". Skin Pharmacology and Applied Skin Physiology. 14 (5): 303–315. doi:10.1159/000056361. PMID 11586072.
source: https://en.wikipedia.org/wiki/Motretinide

    by LabLynx

    Website

    Related Posts